Orphazyme co-founder becomes board chair at biotech startup
Anders Hinsby will sit at the head of the table at board meetings for Pephexia Therapeutics.
by christian bundgaard, translated by catherine brett
In 2019, Anders Hinsby left his role as CEO of Orphazyme, a company he helped to establish back in 2010.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
.jpg)
Orphazyme CEO on sale: "It’s sad, but we tried everything"
For subscribers
Former Bioporto CEO to lead board of medtech firm
For subscribers
